Development of a high number, high coverage dog rabies vaccination programme in Sri Lanka.


Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
20 Nov 2019
Historique:
received: 03 05 2019
accepted: 21 10 2019
entrez: 22 11 2019
pubmed: 22 11 2019
medline: 17 1 2020
Statut: epublish

Résumé

Rabies is estimated to cause 59,000 deaths and economic losses of US$8.6 billion every year. Despite several years of rabies surveillance and awareness programmes, increased availability of post-exposure prophylaxis vaccinations and dog population control, the disease still remains prevalent in Sri Lanka. This study reports the roll-out of a high number, high coverage canine rabies vaccination campaign in Sri Lanka, providing estimates for the vaccination coverage achieved, analysing the local dog demographics, and identifying barriers of attendance to static vaccination clinics. A mass dog vaccination campaign was undertaken in Negombo, Sri Lanka. The campaign was composed of static point and door-to-door vaccination stages, with a final survey of vaccination coverage. A large volume of data on the distribution, health, and signalment of vaccinated dogs was collected through a mobile phone application. A logistic regression model was developed to investigate which socio-spatial and dog-related factors influenced attendance of owners to static vaccination points. The campaign vaccinated over 7800 dogs achieving a vaccination coverage of 75.8%. A dog:human ratio of 1:17 was estimated. Most dogs were owned, and the dog population was mostly male, adult, and non-sterilized. Unawareness, unavailability and handling problems were the most common reasons given by owners to explain failure to attend a static vaccination point. The regression analysis showed that increasing distance to a static point, in addition to young age and poor health of the dog, were associated with a decrease in the likelihood of attendance to a static vaccination points. This study demonstrates the feasibility of high number, high coverage vaccination campaigns in Sri Lanka. The information on dog ecology and barriers of attendance to static point vaccination clinics will facilitate development of future vaccination campaigns.

Sections du résumé

BACKGROUND BACKGROUND
Rabies is estimated to cause 59,000 deaths and economic losses of US$8.6 billion every year. Despite several years of rabies surveillance and awareness programmes, increased availability of post-exposure prophylaxis vaccinations and dog population control, the disease still remains prevalent in Sri Lanka. This study reports the roll-out of a high number, high coverage canine rabies vaccination campaign in Sri Lanka, providing estimates for the vaccination coverage achieved, analysing the local dog demographics, and identifying barriers of attendance to static vaccination clinics.
METHODS METHODS
A mass dog vaccination campaign was undertaken in Negombo, Sri Lanka. The campaign was composed of static point and door-to-door vaccination stages, with a final survey of vaccination coverage. A large volume of data on the distribution, health, and signalment of vaccinated dogs was collected through a mobile phone application. A logistic regression model was developed to investigate which socio-spatial and dog-related factors influenced attendance of owners to static vaccination points.
RESULTS RESULTS
The campaign vaccinated over 7800 dogs achieving a vaccination coverage of 75.8%. A dog:human ratio of 1:17 was estimated. Most dogs were owned, and the dog population was mostly male, adult, and non-sterilized. Unawareness, unavailability and handling problems were the most common reasons given by owners to explain failure to attend a static vaccination point. The regression analysis showed that increasing distance to a static point, in addition to young age and poor health of the dog, were associated with a decrease in the likelihood of attendance to a static vaccination points.
CONCLUSION CONCLUSIONS
This study demonstrates the feasibility of high number, high coverage vaccination campaigns in Sri Lanka. The information on dog ecology and barriers of attendance to static point vaccination clinics will facilitate development of future vaccination campaigns.

Identifiants

pubmed: 31747889
doi: 10.1186/s12879-019-4585-z
pii: 10.1186/s12879-019-4585-z
pmc: PMC6868729
doi:

Substances chimiques

Rabies Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

977

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/J004235/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/P013740/1
Pays : United Kingdom

Références

PLoS Negl Trop Dis. 2014 Jun 19;8(6):e2935
pubmed: 24945697
Vaccine. 1996 Feb;14(3):185-6
pubmed: 8920697
PLoS Negl Trop Dis. 2015 May 15;9(5):e0003784
pubmed: 25978406
Int J Epidemiol. 1998 Oct;27(5):878-84
pubmed: 9839747
Acta Trop. 2000 Feb 25;75(1):95-108
pubmed: 10708011
Vet Med Sci. 2016 Feb 10;2(2):106-116
pubmed: 29067184
Vet Rec. 2015 Aug 8;177(6):150
pubmed: 26109286
Lancet Neurol. 2013 May;12(5):498-513
pubmed: 23602163
PLoS Negl Trop Dis. 2016 Jul 14;10(7):e0004824
pubmed: 27414810
World Health Organ Tech Rep Ser. 2013;(982):1-139, back cover
pubmed: 24069724
PLoS Negl Trop Dis. 2017 Mar 17;11(3):e0005460
pubmed: 28306717
PLoS Negl Trop Dis. 2018 Jan 11;12(1):e0006159
pubmed: 29324737
Bioinformatics. 2005 Oct 15;21(20):3940-1
pubmed: 16096348
Soc Sci Med. 1983;17(9):563-70
pubmed: 6879255
Bull World Health Organ. 2005 May;83(5):360-8
pubmed: 15976877
PLoS Negl Trop Dis. 2015 Apr 16;9(4):e0003709
pubmed: 25881058
Acta Trop. 2009 Oct;112(1):33-7
pubmed: 19540826
PLoS One. 2018 Jul 26;13(7):e0200942
pubmed: 30048469
Vaccine. 2016 Jan 20;34(4):571-577
pubmed: 26631415
Vet Microbiol. 2006 Oct 5;117(1):43-50
pubmed: 16701966
PLoS Negl Trop Dis. 2010 Feb 23;4(2):e626
pubmed: 20186330
PLoS Negl Trop Dis. 2017 Oct 9;11(10):e0005946
pubmed: 28991898
WHO South East Asia J Public Health. 2016 Sep;5(2):113-116
pubmed: 28607238
PLoS Biol. 2009 Mar 10;7(3):e53
pubmed: 19278295
Int J Health Plann Manage. 2003 Oct-Dec;18(4):293-311
pubmed: 14727709
PLoS Negl Trop Dis. 2014 Nov 13;8(11):e3160
pubmed: 25393023
Prev Vet Med. 2015 Jun 15;120(2):203-209
pubmed: 25953653
BMC Infect Dis. 2015 Dec 29;15:589
pubmed: 26715371
Lancet. 2014 Oct 11;384(9951):1389-99
pubmed: 24828901

Auteurs

Carlos Sánchez-Soriano (C)

The Royal (Dick) School of Veterinary Studies, The University of Edinburgh, Easter Bush Veterinary Centre, Roslin, Midlothian, EH25 9RG, UK. C.Sanchez-Soriano@ed.ac.uk.

Andrew D Gibson (AD)

The Roslin Institute, Division of Genetics and Genomics, Easter Bush Veterinary Centre, Roslin, Midlothian, UK.
Mission Rabies, Cranborne, Dorset, UK.

Luke Gamble (L)

Mission Rabies, Cranborne, Dorset, UK.

Jordana L Burdon Bailey (JL)

Mission Rabies, Cranborne, Dorset, UK.

Samantha Green (S)

Dogstar Foundation, Negombo, Western Province, Sri Lanka.

Mark Green (M)

Dogstar Foundation, Negombo, Western Province, Sri Lanka.

Barend M deC Bronsvoort (BMD)

The Royal (Dick) School of Veterinary Studies, The University of Edinburgh, Easter Bush Veterinary Centre, Roslin, Midlothian, EH25 9RG, UK.
The Roslin Institute, Division of Genetics and Genomics, Easter Bush Veterinary Centre, Roslin, Midlothian, UK.

Ian G Handel (IG)

The Royal (Dick) School of Veterinary Studies, The University of Edinburgh, Easter Bush Veterinary Centre, Roslin, Midlothian, EH25 9RG, UK.
The Roslin Institute, Division of Genetics and Genomics, Easter Bush Veterinary Centre, Roslin, Midlothian, UK.

Richard J Mellanby (RJ)

The Royal (Dick) School of Veterinary Studies, The University of Edinburgh, Easter Bush Veterinary Centre, Roslin, Midlothian, EH25 9RG, UK.

Stella Mazeri (S)

The Royal (Dick) School of Veterinary Studies, The University of Edinburgh, Easter Bush Veterinary Centre, Roslin, Midlothian, EH25 9RG, UK.
The Roslin Institute, Division of Genetics and Genomics, Easter Bush Veterinary Centre, Roslin, Midlothian, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH